Overview

Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2026-12-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of delpazolid add-on therapy in Patients with Refractory Mycobacterium abscessus Complex Pulmonary disease

Phase:

PHASE2

Details

Lead Sponsor:

LigaChem Biosciences, Inc.

Treatments:

delpazolid